BenevolentAI

BenevolentAI

Biotechnology Research

London, Greater London 58,308 followers

Accelerate scientific breakthroughs with AI

About us

BenevolentAI is a pioneer and leader in applying advanced AI to drug discovery and development.  In a world where drug development failure rate exceeds 90% and thousands of complex diseases lack treatment, our technology can increase the probability of success and reduce timelines.  Our proprietary Benevolent PlatformTM is one of the industry's most established and validated AI drug discovery technologies. Expertise across Target Identification, Chemistry and Drug Repurposing enables us to deliver across the entire R&D lifecycle. We unite science and technology to serve patients with complex diseases – because it matters. BenevolentAI is headquartered in London, with our own state-of-the-art wet-labs in Cambridge, UK.

Website
http://benevolent.com
Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
London, Greater London
Type
Public Company
Founded
2013
Specialties
Artificial Intelligence, Drug Development, Machine Learning, Deep Learning, Big Data, Drug Discovery, Technology, Pharmaceuticals, and TechBio

Locations

Employees at BenevolentAI

Updates

Similar pages

Browse jobs

Funding

BenevolentAI 3 total rounds

Last Round

Private equity

US$ 90.0M

See more info on crunchbase